Search Results
Results found for "Timo De Groof"
- Asking Better Questions in Science: A Practical Guide for Emerging Researchers
Yet one well-timed question can unlock clarity, accelerate a stalled project, or even spark a collaboration Fear of wasting someoneâs time. Science Late in the conversation, JB offers advice that should be printed on the badge of every first-time
- Accelerating GPCR Drug Discovery: What 40 Years of Pharmacology Reveal
Early In Vivo Wins the Race When is the right time to move beyond cell assays? âTarget residence time in vivo correlates beautifully with activity. Modern real-time assays can deliver these insights earlier, faster, and cheaper than most teams assume Every misaligned study is not just wasted budgetâitâs lost time. Program Kill vs.
- New Tools, Smart Signals, and The Kenakin Brief
The time youâll save is yours. Terryâs Corner is coming soon. Dr. The time youâll save is yours. Terryâs Corner is coming soon. Stay curious, The Dr. GPCR Team
- The Hidden Cost of Unclear Biotech Positioning
Over time, this constant adjustment drains confidence and momentum, even when the science is strong. Over time, founders compensate by explaining more, not realizing that explanation is a symptom, not a The most damaging effect is subtle. â Founders start adapting their message in real time , trying to mid-conversation , which increases confidence and coherence Alignment can be tested quickly , saving time from founders. đ They no longer carry the responsibility of making every detail meaningful in real time
- How Early Strategic Decision Making Creates Alignment and Better Results
through dramatic moves or bold announcements, but through subtle direction-setting that compounds over time By the time results show up, direction has already been set. Timing shapes results. Early decisions set the direction long before outcomes appear. Over time, this friction compounds and erodes confidence, even when the underlying strategy is sound. It is something you design early, one deliberate decision at a time .
- The Hidden Cost of Ambition in Biotech Leadership
The real challenge for biotech leaders is simple and demanding at the same time: đ How do you stay ambitious It means structuring how that vision unfolds over time . đ The strongest biotech leaders understand Every expansion consumes capital, time, and leadership bandwidth. The external narrative becomes coherent. â And over time, biotech fundraising becomes less about persuasion
- Integrating Fluorescent Ligands into Flow Cytometry: Enhancing GPCR Analysis Beyond Traditional Antibody Staining
staining is a technique that helps differentiate cells and has been used in flow cytometry for a long time This facilitates the study of receptor dynamics, ligand binding and signaling in real time. the advantages enumerated previously, fluorescent ligands provide new capabilities: -Â Â Â Â Â Â Â Â Â Â Â Real time
- Terryâs Corner, Celtarys' Leap, and the $7B GPCR Horizon
and early safety in real development contexts Advance with nuanced lessons on allostery, residence time Read how scientific need and timing drove the leap from academia to application. Â
- The Real Cost of Strategic Overload in Biotech
At the same time, the team is preparing for biotech fundraising. When multiple programs advance at the same time, trade-offs become implicit instead of explicit. At the same time, boards expect growth, grants require alignment, and potential partners introduce new By the time biotech fundraising begins, investors are not only evaluating data.
- Illuminating GPCR Research: FRET and BRET-Based Sensors Shed Light on Cellular Signaling
Bioluminescence Resonance Energy Transfer (BRET), has revolutionized the study of GPCRs by enabling real-time One of the significant advantages of FRET and BRET-based sensors is their ability to provide real-time discovery efforts by enabling the precise characterization of pharmacological interventions in real time Galés, C., et al., Real-time monitoring of receptor and G-protein interactions in living cells. Eidne, Bioluminescence resonance energy transfer (BRET) for the real-time detection of protein-protein
- Bell-Evans model and steered molecular dynamics in uncovering the dissociation kinetics of ligands..
kinetics-based drug development have become immensely interested in predicting the drug target residence time Screening drug candidates in terms of their computationally predicted residence times, which is a measure from steered molecular dynamics simulations and the Bell-Evans model to predict the absolute residence times We have predicted the absolute ligand residence times on the timescale of seconds.
- Understanding the Journey: Catherine Demery's Path to Addiction Science
Learning the Lab, Learning Herself During her time at the contract research organization (CRO) in Ann that would reshape her academic ambitions. â...I had a light bulb moment where I felt for the first time For the first time, she saw herself as a future researcher, not just a technician or a student.
- Orthosteric vs Allosteric Interactionsâ and the pHSense Shift in Internalization
Separate effect size from time:  Use allosteric modulators to expand therapeutic index and reduce overdose The Advantages Live-cell imaging:  visualize receptorâligand interactions in real time, without disturbing Why It Matters In the CNS, where receptor localization and real-time signaling shape therapeutic outcomes Access this weekâs full Premium Edition here †What our members say "This came at just the most perfect time
- Exclusive Access: Terry's Corner is LIVE + Your Premium Member Discount!
GPCR Premium Members a significantly reduced access  to Terry's Corner for a limited time. Â
- GPCR Happy Hour Boston 2026 â April 29 | Dr. GPCR Community Event
already share something (a deep commitment to GPCR science) even if they're meeting for the first time GPCR online for years or you're hearing about us for the first time, walk in. You already belong.
- Beyond HEK293 â Terry HĂ©bert on iPSC-Derived GPCR Models, Live April 16,
Thursday, April 16, 1:00 PM ET Â â note the adjusted time. Send your questions ahead of time to Terry@DrGPCR.org Free for Kenakin Brief subscribers.
- From GPCR Data Chaos to Decisive Action
Real-Time Global Insight As founder of Dr. Even strong science stalls without operational structure â Scattered data = missed insights = wasted time
- From Ox Liver to AI: How the History of Pharmacology Shapes Its Future
Whether you're stepping into pharmacology for the first time or rekindling your interest, this lesson
- Beyond the Probe: Scaling Innovation From the Bench to Product Launch
positions, tailor activity (agonist or antagonist), and retain biological function, all while skipping the time-consuming
- Science Needs Rigor, But Also Joy
Watch Episode 166 Whenâs the last time you argued in the lab about injecting GTPÎłS?
- Why Fundraising Mistakes Kill Strong Biotech Startups
Over time, these small shifts accumulate. Roadmaps bend toward what sounds fundable instead of what creates durable value. đ Over time, the company Programs move forward because they sound fundable, not because the data justifies the timing. By the time founders sense that something feels off, the logic has already normalized. đ The company
- Why GPCR Biologic Drugs Stabilize Active States Small Molecules Struggle to Reach
Why an Orthosteric Small Molecule Has a Harder Time A small molecule binding the same orthosteric site may be encountering the limit of what a small molecule can do at a site optimized over evolutionary time
- đ° GPCR Weekly News, April 29 to May 5, 2024
If you aren't joining us this time, stay tuned for more Dr. GPCR University content coming soon.
- How GPCR Spatial Signaling Sparked a Scientific Journey
Instead of dreading lab time, she found herself chasing questions late into the night. By understanding how signaling is organized in time and space, her team is opening doors to next-generation
- Reflections on My PhD Journey: Lessons Learned
generating data when experiments are working smoothly, but neglecting to analyze that data in real-time Procrastination may seem tempting, but tackling your work incrementally will save time and reduce stress
- Integrated GPCR Drug Discovery: A Structured Framework for Modern Programs
Ask your questions in real time â then revisit the material anytime. Structured continuity. Â Terry Kenakin (for a limited time).
- Early Safety Assays: Identifying Showstoppers in GPCR Drug Discovery Pipelines Early
Cytotoxicity is multifactorial and mechanism-dependent Early in vitro screens save time by revealing As GPCR science and pharmacological innovation accelerate, timely guidance from foundational to advanced
- GPCR Allosteric Modulation: Why Allostery is the Engine of Drug Discovery
This has direct implications for: Assay timing and readout design Misclassification of lead candidates walk away with tools to: Interpret probe-dependent effects Model and anticipate longer equilibration times
- The Hidden Burn: How Internal Misalignment Drains Your Biotechâs Runway
And by the time you catch it, your burn rate is up and your traction is down. By the time it surfaces, youâve lost two months of budget and alignment. 2ïžâŁ Milestone redefinition slowly redirects energy, delays clarity, and erodes momentum. đ You donât notice it until youâre out of time
- Scientific Isolation: The Real Reason Early Biotechs Lose Traction
They chase direction, intent, and timing. In practice, founders overestimate how much time they have, usually by several months.


























